Researchers examined the differences in circadian biology between the ancestors of modern humans and the archaic hominins such as Denisovans and Neanderthals and the contribution of archaic introgression in human chronotypes by using genomes to trace chronotype evolution from archaic hominins to modern-day humans.
Rapport Therapeutics sets out for $122M Nasdaq debut as IPO backlog seeks fresh air
Clinical-stage neuroscience biotech Rapport Therapeutics will seek about $122 million in net proceeds from its initial public offering, according to new securities paperwork outlining its